BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20570198)

  • 1. Four novel mutations identified in Norwegian patients result in intermittent maple syrup urine disease when combined with the R301C mutation.
    Brodtkorb E; Strand J; Backe PH; Lund AM; Bjørås M; Rootwelt T; Rootwelt H; Woldseth B; Eide L
    Mol Genet Metab; 2010 Aug; 100(4):324-32. PubMed ID: 20570198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of intermittent maple syrup urine disease: novel mutations in the E2 gene of the branched-chain alpha-keto acid dehydrogenase complex.
    Tsuruta M; Mitsubuchi H; Mardy S; Miura Y; Hayashida Y; Kinugasa A; Ishitsu T; Matsuda I; Indo Y
    J Hum Genet; 1998; 43(2):91-100. PubMed ID: 9621512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maple syrup urine disease: domain structure, mutations and exon skipping in the dihydrolipoyl transacylase (E2) component of the branched-chain alpha-keto acid dehydrogenase complex.
    Chuang DT; Fisher CW; Lau KS; Griffin TA; Wynn RM; Cox RP
    Mol Biol Med; 1991 Feb; 8(1):49-63. PubMed ID: 1943690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of twelve novel mutations in patients with classic and variant forms of maple syrup urine disease.
    Henneke M; Flaschker N; Helbling C; Müller M; Schadewaldt P; Gärtner J; Wendel U
    Hum Mutat; 2003 Nov; 22(5):417. PubMed ID: 14517957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four novel mutations of the BCKDHA, BCKDHB and DBT genes in Iranian patients with maple syrup urine disease.
    Zeynalzadeh M; Tafazoli A; Aarabi A; Moghaddassian M; Ashrafzadeh F; Houshmand M; Taghehchian N; Abbaszadegan MR
    J Pediatr Endocrinol Metab; 2018 Jan; 31(2):205-212. PubMed ID: 29306928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2 transacylase-deficient (type II) maple syrup urine disease. Aberrant splicing of E2 mRNA caused by internal intronic deletions and association with thiamine-responsive phenotype.
    Chuang JL; Cox RP; Chuang DT
    J Clin Invest; 1997 Aug; 100(3):736-44. PubMed ID: 9239422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel homozygous mutation (S144I) in a Malay patient with maple syrup urine disease.
    Ali EZ; Yunus ZM; Desa NM; Hock NL
    J Pediatr Endocrinol Metab; 2013; 26(9-10):975-80. PubMed ID: 23729548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational spectrum of maple syrup urine disease in Spain.
    Rodríguez-Pombo P; Navarrete R; Merinero B; Gómez-Puertas P; Ugarte M
    Hum Mutat; 2006 Jul; 27(7):715. PubMed ID: 16786533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of maple syrup urine disease patients from Tunisia.
    Jaafar N; Moleirinho A; Kerkeni E; Monastiri K; Seboui H; Amorim A; Prata MJ; Quental S
    Gene; 2013 Mar; 517(1):116-9. PubMed ID: 23313820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic analysis of MSUD from India reveals mutations causing altered protein truncation affecting the C-termini of E1α and E1β.
    Bashyam MD; Chaudhary AK; Sinha M; Nagarajaram HA; Devi AR; Bashyam L; Reddy EC; Dalal A
    J Cell Biochem; 2012 Oct; 113(10):3122-32. PubMed ID: 22593002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and structural analyses of maple syrup urine disease and identification of a founder mutation in a Portuguese Gypsy community.
    Quental S; Macedo-Ribeiro S; Matos R; Vilarinho L; Martins E; Teles EL; Rodrigues E; Diogo L; Garcia P; Eusébio F; Gaspar A; Sequeira S; Furtado F; Lança I; Amorim A; Prata MJ
    Mol Genet Metab; 2008 Jun; 94(2):148-56. PubMed ID: 18378174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition of the mutation responsible for maple syrup urine disease in Poll Shorthorns and genotyping Poll Shorthorns and Poll Herefords for maple syrup urine disease alleles.
    Dennis JA; Healy PJ
    Res Vet Sci; 1999 Aug; 67(1):1-6. PubMed ID: 10425233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new missense mutation in the BCKDHB gene causes the classic form of maple syrup urine disease (MSUD).
    Miryounesi M; Ghafouri-Fard S; Goodarzi H; Fardaei M
    J Pediatr Endocrinol Metab; 2015 May; 28(5-6):673-5. PubMed ID: 25381949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of gene mutations among South Indian patients with maple syrup urine disease: identification of four novel mutations.
    Narayanan MP; Menon KN; Vasudevan DM
    Indian J Biochem Biophys; 2013 Oct; 50(5):442-6. PubMed ID: 24772966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two novel compound heterozygous mutations in the BCKDHB gene that cause the intermittent form of maple syrup urine disease.
    Guo Y; Liming L; Jiang L
    Metab Brain Dis; 2015 Dec; 30(6):1395-400. PubMed ID: 26239723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two novel mutations in the BCKDHB gene (R170H, Q346R) cause the classic form of maple syrup urine disease (MSUD).
    Wang YP; Qi ML; Li TT; Zhao YJ
    Gene; 2012 Apr; 498(1):112-5. PubMed ID: 22326532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nonsense mutation (R242X) in the branched-chain alpha-keto acid dehydrogenase E1alpha subunit gene (BCKDHA) as a cause of maple syrup urine disease. Mutations in brief no. 160. Online.
    Chinsky J; Appel M; Almashanu S; Costeas P; Ambulos N; Carmi R
    Hum Mutat; 1998; 12(2):136. PubMed ID: 10694918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of a 2-bp (AT) deletion allele and a nonsense (G-to-T) mutant allele at the E2 (DBT) locus of six patients with maple syrup urine disease: multiple-exon skipping as a secondary effect of the mutations.
    Fisher CW; Fisher CR; Chuang JL; Lau KS; Chuang DT; Cox RP
    Am J Hum Genet; 1993 Feb; 52(2):414-24. PubMed ID: 8430702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of zebrafish dihydrolipoamide branched-chain transacylase E2 results in motor dysfunction and models maple syrup urine disease.
    Friedrich T; Lambert AM; Masino MA; Downes GB
    Dis Model Mech; 2012 Mar; 5(2):248-58. PubMed ID: 22046030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 17-bp insertion and a Phe215----Cys missense mutation in the dihydrolipoyl transacylase (E2) mRNA from a thiamine-responsive maple syrup urine disease patient WG-34.
    Fisher CW; Lau KS; Fisher CR; Wynn RM; Cox RP; Chuang DT
    Biochem Biophys Res Commun; 1991 Jan; 174(2):804-9. PubMed ID: 1847055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.